rs746967306

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2

The NM_021098.3(CACNA1H):​c.5852T>A​(p.Val1951Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000681 in 1,555,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000068 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000068 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
5
13

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.583

Publications

9 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12965441).
BP6
Variant 16-1218616-T-A is Benign according to our data. Variant chr16-1218616-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 578030.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5867T>A p.Val1956Glu missense_variant Exon 32 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5870T>A p.Val1957Glu missense_variant Exon 32 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5834T>A p.Val1945Glu missense_variant Exon 32 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5867T>A p.Val1956Glu missense_variant Exon 33 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5813T>A p.Val1938Glu missense_variant Exon 33 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5834T>A p.Val1945Glu missense_variant Exon 32 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5795T>A p.Val1932Glu missense_variant Exon 32 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5834T>A p.Val1945Glu missense_variant Exon 32 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5852T>A p.Val1951Glu missense_variant Exon 33 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5852T>A non_coding_transcript_exon_variant Exon 33 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1804T>A non_coding_transcript_exon_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*933T>A non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3703T>A non_coding_transcript_exon_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5296T>A non_coding_transcript_exon_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*826T>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*711T>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1464T>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*519T>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*519T>A non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5834T>A non_coding_transcript_exon_variant Exon 32 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5852T>A non_coding_transcript_exon_variant Exon 33 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5852T>A non_coding_transcript_exon_variant Exon 33 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*968T>A non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1804T>A 3_prime_UTR_variant Exon 32 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*933T>A 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3703T>A 3_prime_UTR_variant Exon 33 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5296T>A 3_prime_UTR_variant Exon 31 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*826T>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*711T>A 3_prime_UTR_variant Exon 33 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1464T>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*519T>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*519T>A 3_prime_UTR_variant Exon 34 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*968T>A 3_prime_UTR_variant Exon 33 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.0000680
AC:
10
AN:
147006
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000255
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000135
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000897
Gnomad OTH
AF:
0.000496
GnomAD2 exomes
AF:
0.0000999
AC:
17
AN:
170152
AF XY:
0.0000984
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000766
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000375
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000216
GnomAD4 exome
AF:
0.0000681
AC:
96
AN:
1408846
Hom.:
0
Cov.:
38
AF XY:
0.0000690
AC XY:
48
AN XY:
695788
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32378
American (AMR)
AF:
0.0000269
AC:
1
AN:
37230
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37050
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79850
European-Finnish (FIN)
AF:
0.000329
AC:
16
AN:
48644
Middle Eastern (MID)
AF:
0.000354
AC:
2
AN:
5646
European-Non Finnish (NFE)
AF:
0.0000636
AC:
69
AN:
1084552
Other (OTH)
AF:
0.000137
AC:
8
AN:
58374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000680
AC:
10
AN:
147100
Hom.:
0
Cov.:
30
AF XY:
0.0000699
AC XY:
5
AN XY:
71524
show subpopulations
African (AFR)
AF:
0.0000254
AC:
1
AN:
39322
American (AMR)
AF:
0.000135
AC:
2
AN:
14800
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4962
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4622
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9848
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000897
AC:
6
AN:
66894
Other (OTH)
AF:
0.000491
AC:
1
AN:
2038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000822
Hom.:
0
Bravo
AF:
0.0000831
ExAC
AF:
0.0000342
AC:
4

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Aug 24, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
0.0065
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
20
DANN
Benign
0.96
DEOGEN2
Benign
0.20
T;.;.;.
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.45
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.65
T;T;T;.
M_CAP
Pathogenic
0.42
D
MetaRNN
Benign
0.13
T;T;T;T
MetaSVM
Uncertain
0.056
D
MutationAssessor
Uncertain
2.1
M;.;.;.
PhyloP100
0.58
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.7
N;.;N;N
REVEL
Uncertain
0.46
Sift
Benign
0.63
T;.;T;T
Sift4G
Benign
0.84
T;.;T;T
Polyphen
0.93
P;.;P;P
Vest4
0.60
MVP
0.93
ClinPred
0.13
T
GERP RS
2.3
Varity_R
0.38
gMVP
0.44
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746967306; hg19: chr16-1268616; API